The documents, which were shared with Children’s Health Defense (CHD) last week, also include emails between top officials at U.S. public health agencies showing that Israel’s Ministry of Health contacted them about myocarditis related to the shots as early as Feb. 28, 2021.
Ministry of Health Deputy Director Roee Singer informed the Centers for Disease Control and Prevention (CDC) that the health ministry had concerns about “a large number of myocarditis and pericarditis cases in young individuals” following the Pfizer shot and sought to discuss those concerns with the CDC.
A source who obtained documents from the U.S. Department of State shared Israel’s data on myocarditis rates and U.S. public health agencies’ correspondence with CHD. The documents include a slide presentation by Israel’s Ministry of Health Division of Epidemiology dated March 31, 2021.
The slides showed that by the end of March 2021, 5.2 million Israelis received the first dose of the vaccine and 4.8 million received the second dose. The incidence of myocarditis following dose 1 was 1.1 per million, and 11.7 per million following dose 2 — a 964% increase in incidence between the two.
The CDC didn’t publicly admit the link between the COVID-19 shots and myocarditis until May 27, 2021, even though Israel’s Ministry of Health had reached out in February 2021, and the agency had the slide presentation soon after that.
The slide presentation was included in an April 5, 2021, email that Dr. Lauri Markowitz, co-lead of the CDC’s Vaccine Safety Technical Work Group, sent to her staff.
CHD Senior Scientist Karl Jablonowski, who along with CHD Chief Scientific Officer Brian Hooker was among the first to detail the deception around myocarditis, told The Defender that the Israeli document amounts to a safety surveillance study of 5 million people — and it flags myocarditis as an “undeniably strong signal.”
